Albumin for hyperacute stroke: another failed neuroprotectant

Somehow I missed this in Sept. 2013.

It probably invalidates this trial; but I'm not paying to find out. Thats what your doctor is for.

The Albumin in Acute Stroke Part 1 Trial

The failed one here; no abstract.

http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2813%2970212-6/fulltext 

The Lancet Neurology, Volume 12, Issue 11, Pages 1036 - 1037, November 2013

<Previous Article|Next Article>

doi:10.1016/S1474-4422(13)70212-6Cite or Link Using DOI

Published Online: 27 September 2013

Copyright © 2013 Elsevier Ltd All rights reserved.

Philip M W Bath a

Treatment options for acute ischaemic stroke are slowly accruing and at present include thrombolysis, aspirin, hemicraniectomy, and stroke-unit care. However, two types of intervention have repeatedly not been shown to be efficacious in trials: anticoagulation 1 and neuroprotection. 2 In the past, neuroprotection referred to drugs that modulate neurotransmission (eg, glutamate), but now the term is used by some experts to include any type of intervention that preserves neuronal structure and functio ...

To read this article in full you will need to login or make a payment